ATE259244T1 - Vermeidung von gastrointestinaler schädigung - Google Patents

Vermeidung von gastrointestinaler schädigung

Info

Publication number
ATE259244T1
ATE259244T1 AT97943048T AT97943048T ATE259244T1 AT E259244 T1 ATE259244 T1 AT E259244T1 AT 97943048 T AT97943048 T AT 97943048T AT 97943048 T AT97943048 T AT 97943048T AT E259244 T1 ATE259244 T1 AT E259244T1
Authority
AT
Austria
Prior art keywords
gastrointestinal damage
avoiding gastrointestinal
damage
avoiding
indomethacine
Prior art date
Application number
AT97943048T
Other languages
English (en)
Inventor
Wendy Susan Johnson
Raymond John Playford
Original Assignee
Shs Int Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shs Int Ltd filed Critical Shs Int Ltd
Application granted granted Critical
Publication of ATE259244T1 publication Critical patent/ATE259244T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18Growth factors; Growth regulators
    • A61K38/1841Transforming growth factor [TGF]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97943048T 1996-09-20 1997-09-19 Vermeidung von gastrointestinaler schädigung ATE259244T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9619660.5A GB9619660D0 (en) 1996-09-20 1996-09-20 Prevention of gastrointestinal damage
PCT/GB1997/002574 WO1998011910A1 (en) 1996-09-20 1997-09-19 Prevention of gastrointestinal damage

Publications (1)

Publication Number Publication Date
ATE259244T1 true ATE259244T1 (de) 2004-02-15

Family

ID=10800241

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97943048T ATE259244T1 (de) 1996-09-20 1997-09-19 Vermeidung von gastrointestinaler schädigung

Country Status (7)

Country Link
EP (1) EP0927042B1 (de)
AT (1) ATE259244T1 (de)
AU (1) AU4466597A (de)
DE (1) DE69727583T2 (de)
ES (1) ES2216170T3 (de)
GB (1) GB9619660D0 (de)
WO (1) WO1998011910A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU741299B2 (en) * 1998-04-30 2001-11-29 N.V. Nutricia A food composition and method of using same
AUPP327198A0 (en) * 1998-04-30 1998-05-21 Northfield Laboratories Pty Ltd A food composition and method of using same
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
EP1597978A1 (de) 2004-05-17 2005-11-23 Nutricia N.V. Synergie von GOS und polyfruktose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
EP1723951A1 (de) * 2005-04-21 2006-11-22 N.V. Nutricia Nahrungsergänzungspräparat mit Oligosacchariden für eine Kategorie von HIV Patienten
EP1789073A4 (de) 2004-09-14 2011-06-08 Nexcell Biosciences Inc Isolierung von wachstums- und differenzierungsfaktoren aus colostrum
US7426440B2 (en) 2004-09-24 2008-09-16 Nutritional Bioscience Ltd. Repair and protection factor scoring method for bioactive agents
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0269408A3 (de) * 1986-11-26 1989-08-30 Genentech, Inc. TGF-Beta für die Behandlung von entzündlichen Erkrankungen
DK513589A (da) * 1988-10-20 1990-04-21 Smithkline Beecham Corp Human epitelcelleomdannende vaekstfaktor og fremgangsmaade til fremstilling deraf samt farmaceutisk middel indeholdende vaekstfaktoren
AUPN271295A0 (en) * 1995-05-02 1995-05-25 Gropep Pty Ltd Method of treatment
DK0545946T3 (da) * 1990-07-13 2005-05-23 Gropep Ltd Vækstfremmende middel
US5434135A (en) * 1990-08-02 1995-07-18 Indu Parikh Growth factor compositions, preparation and use
ES2123004T3 (es) * 1991-04-12 1999-01-01 Creative Biomolecules Inc Uso de factor de crecimiento derivado de plaquetas en la preparacion de un medicamento para el tratamiento de ulceras gastrointestinales.
EP0527283B1 (de) * 1991-08-12 1997-11-26 Societe Des Produits Nestle S.A. Nahrungsmittelzusammensetzung
AU2884092A (en) * 1991-10-15 1993-05-21 Gastrone, Inc. Epidermal growth factor therapy for non-gastroduodenal lesions
AU707340B2 (en) * 1993-03-26 1999-07-08 Biovitrum Ab (Publ) Therapeutic uses of keratinocyte growth factor
EP0711171B1 (de) * 1993-06-23 2002-09-04 Novatreat Oy Eine pharmazeutische oder kosmetische zubereitung, die eine kolostrumfraktion enthält und deren medizinische verwendung
US5451411A (en) * 1993-10-15 1995-09-19 University Of Washington Methods and compositions for the oral delivery of therapeutic agents
AUPM534794A0 (en) * 1994-04-28 1994-05-19 Gropep Pty Ltd Modified milk growth factor

Also Published As

Publication number Publication date
WO1998011910A1 (en) 1998-03-26
AU4466597A (en) 1998-04-14
EP0927042A1 (de) 1999-07-07
DE69727583D1 (de) 2004-03-18
ES2216170T3 (es) 2004-10-16
GB9619660D0 (en) 1996-11-06
EP0927042B1 (de) 2004-02-11
DE69727583T2 (de) 2005-08-25

Similar Documents

Publication Publication Date Title
SE9504661D0 (sv) New compounds
ES2191208T3 (es) Oxiimino-pregnano-carbolactonas.
EA200101166A1 (ru) Ингибиторы металлопротеаз
FI860914A0 (fi) Fenylkarbamater.
DK1053239T3 (da) Gluccocorticoid-selektive, anti-inflammatoriske midler
NO971889D0 (no) Forbindelser og sammensetninger for levering av aktive midler
IT8722790A0 (it) Composti farmacologicamente attivi, procedimenti per la loro preparazione e composizioni che li contengono.
ATE126215T1 (de) Anti-entzündende 4-aminophenol-derivate.
DK1053240T3 (da) Glucocorticoid-selektiv antiinflammatoriske midler
DE60045508D1 (de) Dalda-analoge und ihre verwendung
ATE239709T1 (de) Racemisches huperzin a
ATE259244T1 (de) Vermeidung von gastrointestinaler schädigung
IT1318667B1 (it) Medicamento antinfiammatorio.
RU95106653A (ru) Производные 2-имидазолин-5-онов и 2-имидазолин-5-тионов и фунгицидные композиции на их основе
ATE253923T1 (de) Verhütung von magen-darm schäden
ATE216254T1 (de) Pharmazeutische zusammensetzungen enthaltend cyclosporin und einen träger mit mindestens einer ester-alpha-glycerophosphorsäure
PT1244643E (pt) Inibidores da triptase
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
ES2091571T3 (es) Nuevos derivados peptidicos activos en los procesos de adhesion celular, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
SU1549026A1 (ru) 4-Карбэтокси-4-(2-п-толиламинотиазолил-4)-гексановая кислота, проявляющая противовоспалительную активность
AR012449A1 (es) Kodaistatinas a, b, c y d, proceso para su produccion, y su uso.
IT1274024B (it) Derivati polimerici del benzopiran-2-one ad attivita' immunotropa, loro uso e composizioni farmaceutiche che li contengono
IT1274022B (it) Derivati della cumarina ad attivita' farmacologica, loro uso e composizioni farmaceutiche che li contengono
IT1197892B (it) Composizioni farmaceutiche ad attivita' cicatrizzante
SU1783774A1 (ru) Натриевая соль n-(3-хлорбутен-2-ил)антраниловой кислоты, проявляющая противовоспалительную и анальгетическую активность

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0927042

Country of ref document: EP

EEIH Change in the person of patent owner